Intravenous Chemotherapy and Plant-based Dietary Supplements
キーワード
概要
説明
- Determine the quantitative impact of the use of dietary supplements by patients with breast cancer and treated in a neo-adjuvant and/or adjuvant condition by IV chemotherapy in day hospital.
- Determine an over-risk of disruption of liver balance in the population of patients taking Desmodium.
- Gather a critical mass of relevant information with the objective of carrying out the evaluation and analysis of cancer care practices related to the intake of dietary supplements.
日付
最終確認済み: | 04/30/2019 |
最初に提出された: | 05/14/2019 |
提出された推定登録数: | 05/19/2019 |
最初の投稿: | 05/21/2019 |
最終更新が送信されました: | 01/21/2020 |
最終更新日: | 01/22/2020 |
実際の研究開始日: | 04/01/2019 |
一次完了予定日: | 09/01/2020 |
研究完了予定日: | 09/01/2020 |
状態または病気
介入/治療
Other: dietary supplements group
段階
アームグループ
腕 | 介入/治療 |
---|---|
dietary supplements group dietary supplements questionary | Other: dietary supplements group Patient Questionary Patient to be carried out at the last cure |
適格基準
研究の対象となる年齢 | 18 Years に 18 Years |
研究に適格な性別 | All |
サンプリング方法 | Non-Probability Sample |
健康なボランティアを受け入れる | はい |
基準 | Inclusion Criteria: - breast cancer treated by intra-venous chemotherapy - inclusion at the last cycle (cure) - all chemotherapy cycles realised at ICO Exclusion Criteria: - no breast cancer - metastatic breast cancer - not all chemotherapy cycles realised at ICO - patient who has not finished his chemotherapy |
結果
主な結果の測定
1. evaluate quantitatively the use of dietary supplements in patients during IV chemotherapy [12 months]
二次的な結果の測定
1. Evaluate the impact of taking Desmodium between the first and last cycle of treatment [12 months]
2. Description of dietary supplements taken [12 months]